New method improves gene therapy outcomes

A new study recently published in Nature identifies a method for site-specific gene addition that may reduce adverse effects and lead to safe and more effective gene targeting. The study, conducted by researchers at Stanford and UCSF, was performed on mice with hemophilia B and demonstrated reduced bleeding in the mice and minimal side effects typically associated with other gene addition methods.